Table 4 Univariate and multivariate analysis of overall survival

Univariate analysis

PLR ≥ 150

1.151

0.772–1.715

0.494

NLR ≥ 2.5

1.175

0.806–1.714

0.401

LMR ≥ 2.5

0.488

0.317–0.751

0.001

Age

1.037

1.013–1.060

0.002

Sex (female)

0.831

0.481–1.436

0.507

Pathological stage

0.026*

 Stage I

1.000

 Stage II

1.718

1.148–2.571

0.009

 Stage III

1.980

0.975–4.017

0.059

 Stage IV

2.296

0.317–16.631

0.411

Histological type

0.999*

 Adenocarcinoma

1.000

 Squamous cell carcinoma

0.991

0.651–1.509

0.967

 Large cell carcinoma

1.041

0.518–2.091

0.909

 Other

0.986

0.135–7.190

0.989

Multivariate analysis

LMR ≥ 2.5

0.546

0.352–0.846

0.007

Age

1.041

1.017–1.066

0.001

Sex

 Male

1.000

0.966

 Female

1.013

0.564–1.819

Pathological stage

0.013*

 I

1.000

 II

1.783

1.179–2.697

0.006

 III

2.144

1.047–4.389

0.037

 IV

4.083

0.521–31.995

0.180

Histological type

0.830*

 Adenocarcinoma

1.000

 Squamous cell carcinoma

0.812

0.525–1.255

0.348

 Large cell carcinoma

0.923

0.457–1.864

0.824

 Other

0.929

0.122–7.056

0.943